Vedantra Pharmaceuticals' Other Investors

Vedantra Pharmaceuticals raised a round of funding on , . Investors include Clal Biotechnology Industries.

Vendantra Pharmaceuticals aims to improve immunotherapy outcomes by enhancing adaptive immune responses. Vedantra's platform technologies are able to deliver agents directly to the antigen-presenting …

Articles about Vedantra Pharmaceuticals' Other Investors: